The ZAP70 (Ab-493) Antibody targets the phosphorylated form of ZAP70, a 70-kDa protein kinase essential for T-cell receptor (TCR) signaling. Phosphorylation at Tyr493 is catalyzed by Lck kinase, which activates ZAP70's enzymatic activity and initiates downstream signaling pathways . The antibody's specificity ensures detection of active ZAP70 in immunological studies.
ZAP70 is a Syk-family tyrosine kinase primarily expressed in T and NK cells. Its activation is pivotal for TCR-mediated signaling, enabling immune responses to pathogens. Key functions include:
TCR Signal Transduction: Binds phosphorylated ITAM motifs on the TCR ζ-chain, recruiting downstream effectors such as LAT, SLP76, and PLCγ1 .
T-Cell Development: Critical for thymocyte survival and maturation, particularly CD8+ T-cell differentiation .
Disease Implications: Defects in ZAP70 expression or activity correlate with severe combined immunodeficiency (SCID) and chronic lymphocytic leukemia (B-CLL) progression .
The ZAP70 (Ab-493) Antibody is widely used in immunological studies to monitor T-cell activation and signaling. Example experimental applications include:
Jurkat T-Cell Stimulation: Detects phosphorylated ZAP70 in cells treated with PMA/TPA (200 nM, 10 min) or ATP (5 mM, 1 hr) .
Sample Preparation: Lysates from HL60 cells or breast carcinoma tissues are resolved via SDS-PAGE and probed with the antibody (1:5000 dilution) .
Paraffin-Embedded Tissues: Validated for staining ZAP70 in human breast carcinoma and lymphoid tissues (1:50 dilution) .
Western Blot Results: Jurkat cells treated with PMA/TPA show strong ZAP70 pTyr493 signal, confirming activation-dependent phosphorylation .
Immunohistochemistry: Positive staining in human breast carcinoma tissues highlights ZAP70's role in tumor immune microenvironments .
Phosphorylation of tyrosine 493 (Y493) in the activation loop of ZAP70's kinase domain is critical for its full catalytic activity. This site serves as a molecular switch that transforms ZAP70 from an inactive to an active state following T-cell receptor (TCR) engagement. Biochemical and functional evidence demonstrates that trans-phosphorylation of Y493 by a Src-family protein tyrosine kinase (primarily Lck) is required for antigen receptor-mediated activation of both calcium and ras signaling pathways .
The importance of Y493 phosphorylation has been confirmed through mutational studies where ZAP70 with Y493F substitution significantly impairs TCR-mediated signaling . Interestingly, ZAP70 can also undergo auto-phosphorylation at this site, though Lck-mediated phosphorylation appears to be the predominant mechanism . This phosphorylation event maintains ZAP70 in its active conformation, preventing it from returning to an autoinhibited state .
ZAP70 contains multiple phosphorylation sites that serve distinct regulatory functions:
Unlike Y492 phosphorylation which inhibits ZAP70 function, Y493 phosphorylation is essential for activating the kinase. Interestingly, inhibition of ZAP70 activity leads to increased phosphorylation of Y493, suggesting a negative feedback mechanism that regulates this site and dampens ZAP70 activation . This complex interplay of phosphorylation events creates a finely tuned system for regulating T-cell activation.
For optimal Western blotting results with ZAP70 (Ab-493) antibody, follow these methodological guidelines:
Sample Preparation:
Treat cells with appropriate stimulants to induce phosphorylation (e.g., pervanadate [1mM] for 30 minutes or H₂O₂ [2mM] for 2 minutes after serum starvation) .
Lyse cells in phosphate buffered saline containing phosphatase inhibitors to preserve phosphorylation status.
Load approximately 25μg protein per lane for optimal detection .
Protocol:
Use appropriate dilution (1:500-1:1000) of the primary ZAP70 (Ab-493) antibody .
Incubate with HRP-conjugated secondary antibody (typically goat anti-rabbit IgG at 1:10000 dilution) .
Perform detection using standard ECL methods.
Western blot analysis consistently shows a specific band for phosphorylated ZAP70 at approximately 70 kDa when using Jurkat human acute T cell leukemia cell line as a positive control . The antibody's specificity can be verified by comparing samples from untreated cells versus cells stimulated with pervanadate or H₂O₂ .
For immunohistochemistry applications, the following methodology is recommended:
Protocol:
Use formalin-fixed, paraffin-embedded tissue sections.
Apply heat-induced epitope retrieval in citrate buffer (pH 6.0).
Dilute ZAP70 (Ab-493) antibody at 1:50-1:200 for optimal staining .
Incubate at 4°C overnight or at room temperature for 1-2 hours.
Apply appropriate detection system based on the host species (typically rabbit).
Application Notes:
ZAP70 (Ab-493) antibody has been successfully used to detect endogenous levels of phosphorylated ZAP70 in human breast carcinoma tissue .
The antibody shows reactivity across human, mouse, and rat samples, making it versatile for comparative studies .
Store the antibody at -20°C for long-term preservation, with aliquoting recommended to avoid repeated freeze-thaw cycles .
Using ZAP70 (Ab-493) antibody to study T-cell activation dynamics requires a sophisticated experimental approach:
Methodological Framework:
Time-course experiments: Stimulate T-cells with anti-CD3 antibodies or antigen-presenting cells loaded with specific peptides for varying durations (30 seconds to 30 minutes) .
Quantitative analysis: Use quantitative Western blotting or flow cytometry to measure the kinetics of Y493 phosphorylation relative to other phosphorylation events.
Single-cell analysis: Combine with confocal microscopy and immunofluorescence to examine subcellular localization patterns of activated ZAP70 .
Research has demonstrated that following TCR engagement, Y493 phosphorylation occurs within minutes and can remain elevated for over 10 minutes . This phosphorylation is hierarchical, with Y319 phosphorylation typically preceding Y493 phosphorylation. The binding of Lck to phosphorylated Y319 promotes the activated state of Lck and further facilitates ZAP70 activation through phosphorylation of Y493 .
ZAP70 (Ab-493) antibody provides a valuable tool for investigating autoimmune disease mechanisms:
Experimental Approaches:
Comparative analysis: Examine Y493 phosphorylation levels in T-cells from patients with autoimmune diseases versus healthy controls.
Animal models: Use ZAP70 mutant mouse models (e.g., Zap70(AS)) with selectively blockable catalytic activity to analyze how perturbations in ZAP70 function affect autoimmunity development .
Mechanistic studies: Combine with other molecular tools to investigate how altered ZAP70 signaling affects downstream pathways.
Research has revealed that both hypoactive and hyperactive ZAP70 can lead to autoimmune diseases through distinct mechanisms . Perturbations in ZAP70 function can overcome tolerance mechanisms by affecting the signaling strength required for negative selection during T-cell development or by altering peripheral T-cell activation thresholds . By using ZAP70 (Ab-493) antibody to monitor the phosphorylation status at Y493, researchers can gain insights into how these mechanisms operate in various autoimmune conditions.
Several factors can introduce variability when using ZAP70 (Ab-493) antibody:
Sources of Variability and Solutions:
Phosphorylation Instability:
Stimulation Conditions:
Antibody Specificity:
Storage Conditions:
Distinguishing between different ZAP70 phosphorylation events requires careful experimental design:
Methodological Approaches:
Sequential Immunoprecipitation:
Phosphatase Treatment Controls:
Treat duplicate samples with lambda phosphatase prior to immunoblotting to confirm signal specificity for phosphorylated epitopes.
Mass Spectrometry Validation:
Genetic Approaches:
Research has shown that Y493 phosphorylation can occur even in the absence of ZAP70 catalytic activity, demonstrating that this site can be phosphorylated by other kinases (primarily Lck) and does not strictly require ZAP70 auto-phosphorylation . This distinction is important when interpreting experimental results.
Integration of ZAP70 (Ab-493) antibody into single-cell analysis platforms represents a frontier in immunological research:
Advanced Methodologies:
Mass Cytometry (CyTOF):
Conjugate ZAP70 (Ab-493) antibody with heavy metal isotopes for use in CyTOF workflows.
Enables simultaneous detection of Y493 phosphorylation alongside dozens of other cellular markers.
Allows identification of rare T-cell subpopulations with distinct ZAP70 activation profiles.
Imaging Flow Cytometry:
Single-Cell Phospho-Proteomics:
Use ZAP70 (Ab-493) antibody in fluorescence-activated cell sorting (FACS) to isolate cells with specific phosphorylation signatures.
Subject sorted populations to detailed phospho-proteomic analysis to identify downstream signaling networks.
These techniques reveal the heterogeneity of ZAP70 activation patterns within seemingly homogeneous T-cell populations, providing insights into T-cell functional diversity in health and disease states.
Understanding ZAP70 Y493 phosphorylation has significant implications for immunotherapeutic development:
Therapeutic Considerations:
CAR-T Cell Engineering:
Modulating ZAP70 Y493 phosphorylation status in chimeric antigen receptor (CAR) T-cells could optimize their activation thresholds and effector functions.
ZAP70 (Ab-493) antibody can be used to screen and validate engineered CAR constructs with modified signaling domains.
Small Molecule Development:
Research using selective ZAP70 inhibitors in animal models demonstrates that T-cell effector functions, including cytolytic activity against target cells, are dependent on ZAP70 catalytic activity .
ZAP70 (Ab-493) antibody serves as an essential tool for evaluating the efficacy of novel small molecules targeting ZAP70 signaling in preclinical models.
Biomarker Identification:
Aberrant ZAP70 Y493 phosphorylation patterns may serve as biomarkers for autoimmune diseases or immunodeficiencies.
ZAP70 (Ab-493) antibody enables the development of diagnostic assays to monitor this potential biomarker.
ZAP70 deficiency results in severely impaired immune function, while higher levels of ZAP70 expression are associated with certain B-cell malignancies . Precisely modulating ZAP70 activity through therapeutic intervention could provide new avenues for treating both immunodeficiency and autoimmunity.